🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/12/2021 | 96,51 | 97,60 | 95,72 | 96,89 | +0,66% | 1,95% | 120.546 |
| 07/12/2021 | 94,41 | 97,71 | 93,83 | 96,26 | +3,09% | 4,11% | 107.561 |
| 06/12/2021 | 94,02 | 95,45 | 91,11 | 93,37 | -0,70% | 4,61% | 138.499 |
| 03/12/2021 | 98,71 | 98,71 | 93,31 | 94,02 | -3,95% | 5,48% | 165.750 |
| 02/12/2021 | 96,14 | 98,04 | 94,47 | 97,89 | +1,75% | 3,72% | 146.995 |
| 01/12/2021 | 102,76 | 102,78 | 96,14 | 96,21 | -4,76% | 6,47% | 173.605 |
| 30/11/2021 | 96,18 | 101,89 | 96,07 | 101,01 | +4,30% | 6,05% | 273.953 |
| 29/11/2021 | 100,29 | 100,41 | 96,49 | 96,84 | -1,03% | 3,91% | 178.414 |
| 26/11/2021 | 99,48 | 101,39 | 95,73 | 97,85 | -2,80% | 5,69% | 147.316 |
| 24/11/2021 | 99,62 | 100,90 | 97,62 | 100,67 | +0,55% | 3,29% | 101.149 |
| 23/11/2021 | 102,76 | 103,87 | 98,08 | 100,11 | -3,08% | 5,63% | 234.038 |
| 22/11/2021 | 101,24 | 104,87 | 99,83 | 103,29 | +2,26% | 4,98% | 255.358 |
| 19/11/2021 | 100,40 | 102,01 | 99,13 | 101,01 | +0,74% | 2,86% | 163.185 |
| 18/11/2021 | 101,39 | 101,53 | 100,00 | 100,27 | -0,78% | 1,51% | 163.827 |
| 17/11/2021 | 101,19 | 102,69 | 100,05 | 101,06 | +0,33% | 2,61% | 188.673 |
| 16/11/2021 | 102,31 | 104,69 | 100,06 | 100,73 | -1,61% | 4,52% | 254.396 |
| 15/11/2021 | 100,28 | 102,67 | 98,09 | 102,38 | +1,67% | 4,57% | 341.118 |
| 12/11/2021 | 100,92 | 100,92 | 98,38 | 100,69 | -0,45% | 2,52% | 175.048 |
| 11/11/2021 | 103,34 | 105,61 | 100,76 | 101,15 | -2,24% | 4,69% | 230.191 |
| 10/11/2021 | 96,87 | 106,04 | 95,47 | 103,46 | +9,20% | 10,91% | 543.417 |
| 09/11/2021 | 95,30 | 95,91 | 93,57 | 94,75 | -1,26% | 2,45% | 153.407 |
| 08/11/2021 | 95,65 | 97,57 | 95,24 | 95,96 | +0,40% | 2,44% | 112.370 |
| 05/11/2021 | 97,95 | 99,81 | 94,86 | 95,58 | -2,72% | 5,06% | 297.357 |
| 04/11/2021 | 99,65 | 100,32 | 97,82 | 98,25 | -1,54% | 2,51% | 199.093 |
| 03/11/2021 | 98,37 | 100,37 | 97,44 | 99,79 | +1,29% | 2,99% | 294.952 |
| 02/11/2021 | 94,17 | 98,91 | 92,36 | 98,52 | +4,25% | 6,95% | 234.840 |
| 01/11/2021 | 91,62 | 94,59 | 91,35 | 94,50 | +3,80% | 3,54% | 234.359 |
| 29/10/2021 | 91,42 | 92,10 | 89,96 | 91,04 | -0,45% | 2,35% | 221.855 |
| 28/10/2021 | 87,11 | 91,52 | 87,06 | 91,45 | +5,31% | 5,13% | 209.192 |
| 27/10/2021 | 86,80 | 87,52 | 85,16 | 86,84 | -0,71% | 2,72% | 113.172 |